BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30705407)

  • 1. High-throughput RNAi screening reveals cancer-selective lethal targets in the RNA spliceosome.
    Blijlevens M; van der Meulen-Muileman IH; de Menezes RX; Smit EF; van Beusechem VW
    Oncogene; 2019 May; 38(21):4142-4153. PubMed ID: 30705407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment.
    Siebring-van Olst E; Blijlevens M; de Menezes RX; van der Meulen-Muileman IH; Smit EF; van Beusechem VW
    Mol Oncol; 2017 May; 11(5):534-551. PubMed ID: 28296343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer Cells.
    Blijlevens M; Komor MA; Sciarrillo R; Smit EF; Fijneman RJA; van Beusechem VW
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators.
    Aird D; Teng T; Huang CL; Pazolli E; Banka D; Cheung-Ong K; Eifert C; Furman C; Wu ZJ; Seiler M; Buonamici S; Fekkes P; Karr C; Palacino J; Park E; Smith PG; Yu L; Mizui Y; Warmuth M; Chicas A; Corson L; Zhu P
    Nat Commun; 2019 Jan; 10(1):137. PubMed ID: 30635584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo.
    Chang L; Gong F; Cui Y
    Mol Med Rep; 2015 Jul; 12(1):1197-204. PubMed ID: 25778452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the deregulated spliceosome core machinery in cancer cells triggers mTOR blockade and autophagy.
    Quidville V; Alsafadi S; Goubar A; Commo F; Scott V; Pioche-Durieu C; Girault I; Baconnais S; Le Cam E; Lazar V; Delaloge S; Saghatchian M; Pautier P; Morice P; Dessen P; Vagner S; André F
    Cancer Res; 2013 Apr; 73(7):2247-58. PubMed ID: 23358685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of nucleolin is indispensable to its involvement in the proliferation and migration of non-small cell lung cancer cells.
    Huang F; Wu Y; Tan H; Guo T; Zhang K; Li D; Tong Z
    Oncol Rep; 2019 Jan; 41(1):590-598. PubMed ID: 30320343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
    Xu X; Jiang J; Yao L; Ji B
    Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.
    Zhang K; Li Y; Liu W; Gao X; Zhang K
    Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer.
    Kakumu T; Sato M; Goto D; Kato T; Yogo N; Hase T; Morise M; Fukui T; Yokoi K; Sekido Y; Girard L; Minna JD; Byers LA; Heymach JV; Coombes KR; Kondo M; Hasegawa Y
    Cancer Sci; 2017 Apr; 108(4):732-743. PubMed ID: 28165654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lncRNA MALAT1 contributes to non-small cell lung cancer development via modulating miR-124/STAT3 axis.
    Li S; Mei Z; Hu HB; Zhang X
    J Cell Physiol; 2018 Sep; 233(9):6679-6688. PubMed ID: 29215698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
    Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
    Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long intergenic noncoding RNA-p21 inhibits apoptosis by decreasing PUMA expression in non-small cell lung cancer.
    Yang T; Zhang W; Wang L; Xiao C; Guo B; Gong Y; Liang X; Huang D; Li Q; Nan Y; Xiang Y; Shao J
    J Int Med Res; 2019 Jan; 47(1):481-493. PubMed ID: 30556447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
    Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
    Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA circ_0026134 regulates non-small cell lung cancer cell proliferation and invasion via sponging miR-1256 and miR-1287.
    Chang H; Qu J; Wang J; Liang X; Sun W
    Biomed Pharmacother; 2019 Apr; 112():108743. PubMed ID: 30970529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR‑146a‑5p targets TCSF and influences cell growth and apoptosis to repress NSCLC progression.
    Huang WT; He RQ; Li XJ; Ma J; Peng ZG; Zhong JC; Hu XH; Chen G
    Oncol Rep; 2019 Apr; 41(4):2226-2240. PubMed ID: 30816543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 knockdown mediated by a triazine-modified dendrimer in the treatment of non-small cell lung cancer.
    Huang Q; Li L; Li L; Chen H; Dang Y; Zhang J; Shao N; Chang H; Zhou Z; Liu C; He B; Wei H; Xiao J
    Oncotarget; 2016 Jul; 7(28):44013-44022. PubMed ID: 27259273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA circ_0020123 promotes non-small cell lung cancer progression by acting as a ceRNA for miR-488-3p to regulate ADAM9 expression.
    Wan J; Hao L; Zheng X; Li Z
    Biochem Biophys Res Commun; 2019 Jul; 515(2):303-309. PubMed ID: 31153639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping.
    Wu G; Fan L; Edmonson MN; Shaw T; Boggs K; Easton J; Rusch MC; Webb TR; Zhang J; Potter PM
    RNA; 2018 Aug; 24(8):1056-1066. PubMed ID: 29844105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
    Guo D; Wang Y; Ren K; Han X
    Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.